Cargando…
Simultaneous deactivation of FAK and Src improves the pathology of hypertrophic scar
Hypertrophic scar (HS) is a serious fibrotic skin condition with currently no satisfactory therapy due to undefined molecular mechanism. FAK and Src are two important non-receptor tyrosine kinases that have been indicated in HS pathogenesis. Here we found both FAK and Src were activated in HS vs. no...
Autores principales: | Su, Linlin, Li, Xiaodong, Wu, Xue, Hui, Bo, Han, Shichao, Gao, Jianxin, Li, Yan, Shi, Jihong, Zhu, Huayu, Zhao, Bin, Hu, Dahai |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4867599/ https://www.ncbi.nlm.nih.gov/pubmed/27181267 http://dx.doi.org/10.1038/srep26023 |
Ejemplares similares
-
Src promotes cutaneous wound healing by regulating MMP-2 through the ERK pathway
por: WU, XUE, et al.
Publicado: (2016) -
Adipose tissue-derived stem cells suppress hypertrophic scar fibrosis via the p38/MAPK signaling pathway
por: Li, Yan, et al.
Publicado: (2016) -
Extracellular vesicles from Lactobacillus druckerii inhibit hypertrophic scar fibrosis
por: Han, Fu, et al.
Publicado: (2023) -
The Akt/FoxO/p27(Kip1) axis contributes to the anti‐proliferation of pentoxifylline in hypertrophic scars
por: Yang, Fangfang, et al.
Publicado: (2019) -
Disruption of the association between drug transporter and actin cytoskeleton abolishes drug resistance in hypertrophic scar
por: Su, Linlin, et al.
Publicado: (2016)